Current knowledge and future research directions in treatment-related second primary malignancies

Currently, 17–19% of all new primary malignancies occur in survivors of cancer, causing substantial morbidity and mortality. Research has shown that cancer treatments are important contributors to second malignant neoplasm (SMN) risk. In this paper we summarise current knowledge with regard to treat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EJC Suppl
Auteurs principaux: Morton, Lindsay M., Swerdlow, Anthony J., Schaapveld, Michael, Ramadan, Safaa, Hodgson, David C., Radford, John, van Leeuwen, Flora E.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250537/
https://ncbi.nlm.nih.gov/pubmed/26217162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejcsup.2014.05.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires